SUDA Signs Agreement With Mitsubishi Tanabe
Filed with ASX · · 3 pages · English
Arovella Therapeutics Limited on 6ix
Earlier from Arovella Therapeutics
- ZLD to Invest in Development of Oral Spray Formulations
- SUDA Enters Agreement To Develop Cannabinoid Spray
- SUDA Receives R&D Tax Incentive Refund
- ZolpiMist Market Update
- SUDA Signs Agreement For SUD-001H For US Market
Later from Arovella Therapeutics
- Appendix 4C Amended
- ArTiMist Regulatory Update
- Product Development Market Update
- Rights Issue To Raise Up To $3.44 Million
- Prospectus For Renounceable Pro Rata Offer
Follow Arovella Therapeutics into a list and get an email when it puts out news.
Follow Arovella Therapeutics